company background image
CDX logo

CardieX ASX:CDX Stock Report

Last Price

AU$0.064

Market Cap

AU$18.8m

7D

-4.5%

1Y

-61.2%

Updated

23 Jul, 2024

Data

Company Financials +

CardieX Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for CardieX
Historical stock prices
Current Share PriceAU$0.064
52 Week HighAU$0.23
52 Week LowAU$0.045
Beta1.64
11 Month Change-17.95%
3 Month Change1.59%
1 Year Change-61.21%
33 Year Change-90.86%
5 Year Change-75.38%
Change since IPO-99.09%

Recent News & Updates

Recent updates

What Can We Learn About CardieX's (ASX:CDX) CEO Compensation?

Feb 16
What Can We Learn About CardieX's (ASX:CDX) CEO Compensation?

Shareholders Are Thrilled That The CardieX (ASX:CDX) Share Price Increased 169%

Jan 12
Shareholders Are Thrilled That The CardieX (ASX:CDX) Share Price Increased 169%

Have Insiders Been Buying CardieX Limited (ASX:CDX) Shares?

Dec 07
Have Insiders Been Buying CardieX Limited (ASX:CDX) Shares?

Shareholder Returns

CDXAU Medical EquipmentAU Market
7D-4.5%-1.1%-1.2%
1Y-61.2%25.1%8.6%

Return vs Industry: CDX underperformed the Australian Medical Equipment industry which returned 25.1% over the past year.

Return vs Market: CDX underperformed the Australian Market which returned 8.6% over the past year.

Price Volatility

Is CDX's price volatile compared to industry and market?
CDX volatility
CDX Average Weekly Movement13.9%
Medical Equipment Industry Average Movement9.7%
Market Average Movement8.2%
10% most volatile stocks in AU Market16.3%
10% least volatile stocks in AU Market3.2%

Stable Share Price: CDX has not had significant price volatility in the past 3 months.

Volatility Over Time: CDX's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
1994n/aCraig Coopercardiex.com

CardieX Limited designs, manufactures, and markets medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that measures arterial health by collecting digital vascular biomarkers using novel sensors. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; and develops and sells medical devices, digital solutions, and wearables for home health, decentralized clinical trials, and remote patient monitoring.

CardieX Limited Fundamentals Summary

How do CardieX's earnings and revenue compare to its market cap?
CDX fundamental statistics
Market capAU$18.83m
Earnings (TTM)-AU$9.41m
Revenue (TTM)AU$14.16m

1.3x

P/S Ratio

-2.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CDX income statement (TTM)
RevenueAU$14.16m
Cost of RevenueAU$915.99k
Gross ProfitAU$13.24m
Other ExpensesAU$22.65m
Earnings-AU$9.41m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.032
Gross Margin93.53%
Net Profit Margin-66.44%
Debt/Equity Ratio32,735.7%

How did CDX perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.